ArticleTranslational vision science & technology2026
Clinical Implications of the Novel Genetic Polymorphism Associated With Retinal Vein Occlusion: The East Asian GWAS Survey in a Single-Center Taiwanese Cohort.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the single-nucleotide polymorphic features in an East Asian cohort of retinal venous occlusion (RVO) patients, to map pathogenic genes, and to analyze potential pathophysiological associations. Methods: This was a cross-sectional monocentric cohort study involving 172 patients with RVO and 1720 control participants from the Taiwanese population from a single center, Taichung Veterans General Hospital, under the framework of the Taiwan Precision Medicine Initiative (TPMI). DNA samples were collected from a Taiwanese population under the framework of the TPMI. Single nucleotide polymorphism (SNP) exploration was performed using PLINK 2.0. Gene mapping for the selected SNPs and functional analysis were conducted via the SNPXplorer online platform with the R packages biomaRt and clusterProfiler. Single-cell transcriptome mapping was achieved using the published Human Eye Transcriptome Atlas. Results: We report several novel RVO-associated SNPs with suggestive genome-wide association (P < 1 × 10-5), including rs16938701 (STAU2), rs76802456 (FAM189A1), rs995014 (N6AMT1), rs933813, rs6991412 (STAU2), rs79040889, and rs12524176. Among them, the STAU2 single-nucleotide variant, rs16938701, had the most remarkable association (P = 3.19 × 10-7). After mapping to the published human retina single-cell transcriptome atlas, STAU2 exhibited relatively high expression levels in retinal pigment epithelium/choroid complex, microglia, and hyalocyte among all ocular cell types. Conclusions: We identified several novel risk loci significantly associated with the occurrence of RVO and examined potential mechanistic links between specific biological processes and the pathophysiology of RVO. Translational Relevance: These findings provide novel insights into the genetic basis of RVO and highlight key pathways that may inform future research and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.